News

Family cancer burden predicts risk in patients with inflammatory bowel disease

Daraxonrasib demonstrates initial antitumour activity in RAS-mutant lung cancer

Trial shows a less-intensive drug combination is more effective in treating AML

Trial shows a less-intensive drug combination is more effective in treating AML

Researchers report largest study supporting three courses of radiation for children with deadly brain tumour

Study finds folic acid does not elevate toxic formaldehyde in body, offering reassurance to cancer patients

New class of KRAS inhibitors shows promise at shrinking NF1 nerve tumours

Healthier fats linked to longer survival after prostate cancer diagnosis

Mini-tumours reveal new drug combinations for liver cancer

Lung tumour microenvironment established by simultaneous activation of KrasG12D and deletion of neddylation conjugation enzyme UBE2M

Adjuvant immunotherapy shows no survival benefit for NSCLC patients achieving pCR after neoadjuvant treatment

Alcohol-linked cancer’s toll extends far beyond the liver with deaths rising across age groups